|
Market Closed -
Japan Exchange
09:30:00 28/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 6,307.00 JPY | -1.56% |
|
-0.05% | +30.44% |
| 10-26 | Takeda Pharmaceutical Eyes 2027 Japan Filing for Gastric Cancer Treatment | MT |
| 10-25 | Takeda to seek Japan approval for gastric cancer drug next year | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 64.8B | |||||
| 1,143B | |||||
| 647B | |||||
| 506B | |||||
| 384B | |||||
| 350B |
Select your edition
All financial news and data tailored to specific country editions
